E-cigarette vapor may have similar effects to cigarette smoke on bacteria associated with smoking-related illness such as chronic obstructive pulmonary disease (COPD) and asthma, according to a study published in Respiratory Research.
Although e-cigarettes are perceived as a safer alternative to cigarettes, recent research has suggested that acute lung disease may be associated with the use of nicotine-containing e-cigarettes, as well as conventional cigarettes. A team of researchers at the School of Pharmacy, Queen’s University Belfast, UK compared the effects of cigarette smoke and e-cigarette vapor on bacteria known to be associated with smoking-related chronic lung disease.
The authors grew samples of Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus and Pseudomonas aeruginosa while exposing them to extracts of either cigarette smoke (CSE) or e-cigarette vapor (ECVE). A control set of bacterial cultures was grown unexposed to vapor or smoke extracts.
The authors found that exposure to CSE or ECVE appeared to have no negative effect on the growth of these bacteria. However, bacteria exposed to either CSE or ECVE showed increased biofilm formation, an effect not observed in unexposed bacteria. Biofilms are a collective of one or more types of microbe and increased biofilm formation is known to be involved in a wide variety of microbial infections. The finding may indicate that both cigarette smoke and e-cigarette vapor increase the harmfulness of common lung pathogens and promote the establishment of persistent infection.
To investigate changes of harmfulness, or virulence, in bacteria exposed to CSE or ECVE, the authors infected larvae of the moth G. mellonella – a model for infection in humans – with the bacteria to test how this would impact the larvae’s survival. G. mellonella infected with bacteria exposed to CSE or ECVE showed decreased survival compared to those infected with non-exposed bacteria.
In a further experiment, the authors showed that human lung cells infected with to CSE or ECVE exposed bacteria showed increased secretion of Interleukin-8, a key mediator associated with inflammation.
Deirdre Gilpin, the corresponding author said: “A recurring theme of this study is the similarity in the effect of exposure to cigarette smoke compared to e-cigarette vapor on how bacteria behave and how harmful they are. The findings indicate that the effects of vaping on common lung pathogens may be similar to those of smoking.”
The authors caution that the cigarette smoke and e-cigarette vapor extracts used in the experiments were prepared using a similar method and thus may not reflect differences in nicotine exposure due to dissimilarities in smoking behavior between smoking and vaping.
Deirdre Gilpin said: “E-cigarette users take larger and longer puffs, compared to conventional cigarette users, which may increase nicotine delivery. Our model may therefore underestimate the exposure of respiratory pathogens to nicotine contained in e-cigarette vapor.”
For this study, the authors used a common brand of e-cigarettes with no added flavor and bacteria were exposed to vapor and smoke extracts only once. Further research is required to investigate the effect of e-cigarette flavorings and long-term exposure, according to the authors.
Senior Communications Manager
T: +44 (0) 2031 9227 44
Notes to editor:
1. Research article:
Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens
Gilpin et al. Respiratory Research 2019
The article is available at the journal website.
Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BMC's open access policy.
2. Respiratory Research publishes high-quality clinical and basic research, review and commentary articles on all aspects of respiratory medicine and related diseases.
As the leading fully open access journal in the field, Respiratory Research provides an essential resource for pulmonologists, allergists, immunologists and other physicians, researchers, healthcare workers and medical students with worldwide dissemination of articles resulting in high visibility and generating international discussion.
Topics of specific interest include asthma, chronic obstructive pulmonary disease, cystic fibrosis, genetics, infectious diseases, interstitial lung diseases, lung development, lung tumors, occupational and environmental factors, pulmonary circulation, pulmonary pharmacology and therapeutics, respiratory immunology, respiratory physiology, and sleep-related respiratory problems.
3. A pioneer of open access publishing, BMC has an evolving portfolio of high quality peer-reviewed journals including broad interest titles such as BMC Biology and BMC Medicine, specialist journals such as Malaria Journal and Microbiome, and the BMC series. At BMC, research is always in progress. We are committed to continual innovation to better support the needs of our communities, ensuring the integrity of the research we publish, and championing the benefits of open research. BMC is part of Springer Nature, giving us greater opportunities to help authors connect and advance discoveries across the world.